These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 8479289
1. Reduction of calbindin-28k mRNA levels in Alzheimer as compared to Huntington hippocampus. Sutherland MK, Wong L, Somerville MJ, Yoong LK, Bergeron C, Parmentier M, McLachlan DR. Brain Res Mol Brain Res; 1993 Apr; 18(1-2):32-42. PubMed ID: 8479289 [Abstract] [Full Text] [Related]
2. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, McLachlan DR. Brain Res Mol Brain Res; 1992 Apr; 13(3):239-50. PubMed ID: 1317496 [Abstract] [Full Text] [Related]
3. Reduction of thyroid hormone receptor c-ERB A alpha mRNA levels in the hippocampus of Alzheimer as compared to Huntington brain. Sutherland MK, Wong L, Somerville MJ, Handley P, Yoong L, Bergeron C, McLachlan DR. Neurobiol Aging; 1992 Apr; 13(2):301-12. PubMed ID: 1387923 [Abstract] [Full Text] [Related]
4. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Iacopino AM, Christakos S. Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4078-82. PubMed ID: 2140897 [Abstract] [Full Text] [Related]
5. Calbindin D28k mRNA in hippocampus, superior temporal gyrus and cerebellum: comparison between control and Alzheimer disease subjects. Maguire-Zeiss KA, Li ZW, Shimoda LM, Hamill RW. Brain Res Mol Brain Res; 1995 Jun; 30(2):362-6. PubMed ID: 7637586 [Abstract] [Full Text] [Related]
6. Alteration in levels of expression of brain calbindin D-28k and calretinin mRNA in genetically epilepsy-prone rats. Montpied P, Winsky L, Dailey JW, Jobe PC, Jacobowitz DM. Epilepsia; 1995 Sep; 36(9):911-21. PubMed ID: 7649131 [Abstract] [Full Text] [Related]
7. Effect of treatment with the dihydropyridine-type calcium antagonist darodipine (PY 108-068) on the expression of calbindin D-28K immunoreactivity in the cerebellar cortex of aged rats. Amenta F, Mancini M, Naves FJ, Vega JA, Zaccheo D. Mech Ageing Dev; 1995 Jan 13; 77(3):149-57. PubMed ID: 7739263 [Abstract] [Full Text] [Related]
8. Calbindin D-28k and parvalbumin in the rat nervous system. Celio MR. Neuroscience; 1990 Jan 13; 35(2):375-475. PubMed ID: 2199841 [Abstract] [Full Text] [Related]
9. Localization and quantitation of 68 kDa neurofilament and superoxide dismutase-1 mRNA in Alzheimer brains. Somerville MJ, Percy ME, Bergeron C, Yoong LK, Grima EA, McLachlan DR. Brain Res Mol Brain Res; 1991 Jan 13; 9(1-2):1-8. PubMed ID: 1850065 [Abstract] [Full Text] [Related]
10. Calcium homeostasis in ageing: studies on the calcium binding protein calbindin D28K. Lally G, Faull RL, Waldvogel HJ, Ferrari S, Emson PC. J Neural Transm (Vienna); 1997 Jan 13; 104(10):1107-12. PubMed ID: 9503262 [Abstract] [Full Text] [Related]
11. Coexistence of calcium-binding proteins in vagal and glossopharyngeal sensory neurons of the rat. Ichikawa H, Helke CJ. Brain Res; 1997 Sep 12; 768(1-2):349-53. PubMed ID: 9369337 [Abstract] [Full Text] [Related]
12. Calbindin D-28k immunoreactivity in the rat cerebellar cortex: age-related changes. Amenta F, Cavalotta D, Del Valle ME, Mancini M, Sabbatini M, Torres JM, Vega JA. Neurosci Lett; 1994 Aug 29; 178(1):131-4. PubMed ID: 7816322 [Abstract] [Full Text] [Related]
13. Calbindin-D 28k immunoreactivity in the cerebellum of spinocerebellar degeneration. Ishikawa K, Mizusawa H, Fujita T, Ohkoshi N, Doi M, Komatsuzaki Y, Iwamoto H, Ogata T, Shoji S. J Neurol Sci; 1995 Apr 29; 129(2):179-85. PubMed ID: 7608734 [Abstract] [Full Text] [Related]
14. Expression of calbindin-D decreases with age in intestine and kidney. Armbrecht HJ, Boltz M, Strong R, Richardson A, Bruns ME, Christakos S. Endocrinology; 1989 Dec 29; 125(6):2950-6. PubMed ID: 2583050 [Abstract] [Full Text] [Related]
15. Detection of calbindin-D 28k mRNA in rat vestibular ganglion neurons by in situ hybridization. Demêmes D, Moniot B, Lomri N, Thomasset M, Sans A. Brain Res Mol Brain Res; 1991 Jan 29; 9(1-2):153-6. PubMed ID: 1850071 [Abstract] [Full Text] [Related]
16. Combination of alkaline phosphatase in situ hybridization with immunohistochemistry: colocalization of calretinin-mRNA with calbindin and tyrosine hydroxylase immunoreactivity in rat substantia nigra neurons. Heppelmann B, Señaris R, Emson PC. Brain Res; 1994 Jan 28; 635(1-2):293-9. PubMed ID: 7909717 [Abstract] [Full Text] [Related]
17. Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease. Huang Q, Zhou D, Sapp E, Aizawa H, Ge P, Bird ED, Vonsattel JP, DiFiglia M. Neuroscience; 1995 Mar 28; 65(2):397-407. PubMed ID: 7777157 [Abstract] [Full Text] [Related]
18. Induction of calbindin-D 28K gene and protein expression by physiological stimuli but not in calcium-mediated degeneration in rat PC12 pheochromocytoma cells. Vyas S, Michel PP, Copin MC, Biguet NF, Thomasset M, Agid Y. FEBS Lett; 1994 Aug 29; 351(1):53-7. PubMed ID: 8076693 [Abstract] [Full Text] [Related]
19. Parvalbumin and calbindin D-28K in the human entorhinal cortex. An immunohistochemical study. Tuñón T, Insausti R, Ferrer I, Sobreviela T, Soriano E. Brain Res; 1992 Aug 28; 589(1):24-32. PubMed ID: 1422819 [Abstract] [Full Text] [Related]